164
Participants
Start Date
February 18, 2020
Primary Completion Date
December 30, 2022
Study Completion Date
June 27, 2023
optima4BP
"optima4BP establishes a no gaps computational framework in determining the most effective treatment change that can optimize a patient's HTN management towards BP Target. All possible drug combination options available through the 16 anti-HTN drug classes and subclasses are quantitatively evaluated in the context of 5 actions: add a drug, remove a drug, replace a drug, increase a drug dose, and decrease a drug dose. The pharmacological intervention efficacy ranking is computed and the highest ranked treatment recommendation is selected for consideration by the treating physician."
University of California San Francisco, San Francisco
Lead Sponsor
University of California, San Francisco
OTHER
Optima Integrated Health
INDUSTRY